Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov 22;43(47):7899-7901.
doi: 10.1523/JNEUROSCI.1440-23.2023.

Unraveling the Mechanisms Underlying Disordered Sleep in Alzheimer's Disease

Affiliations
Comment

Unraveling the Mechanisms Underlying Disordered Sleep in Alzheimer's Disease

Russell Luke et al. J Neurosci. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proposed brain circuits involved in sleep disturbances of PS19 mice. A, In young PS19 mice, tau pathology predominantly affects wake-promoting structures including, but not limited to, the LC, lateral hypothalamus (LH), and tuberomammillary nucleus (TMN). This early tau pathology may lead to abnormal firing of wake-promoting cells during sleep, consequently inhibiting the thalamic reticular nucleus (TRN), thalamic relay cells, and cortical regions involved in spindle control. With age, tau pathology expands to more regions, including to thalamocortical circuits, NREM-promoting neurons of the ventrolateral preoptic area (VLPO) and parafacial zone (PZ), as well as REM-promoting SLD neurons. Correspondingly, pathology in these regions would result in exacerbation of spindle deficits, decreased and fragmented sleep, and RBD symptoms as seen in old PS19 mice. B, We propose that DORA-12 treatment reduces sleep disturbances in old PS19 mice by antagonizing orexin signaling onto wake-promoting circuits. This would facilitate the invigoration of surviving spindle- and sleep-generating neurons, thus increasing sleep amount, as well as, respectively, restoring spindles and muscle suppression during NREM and REM.

Comment on

References

    1. Antila H, Kwak I, Choi A, Pisciotti A, Covarrubias I, Baik J, Eisch A, Beier K, Thomas S, Weber F, Chung S (2022) A noradrenergic-hypothalamic neural substrate for stress-induced sleep disturbances. Proc Natl Acad Sci USA 119:e2123528119. 10.1073/pnas.2123528119 - DOI - PMC - PubMed
    1. Crimins JL, Rocher AB, Luebke JI (2012) Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathol 124:777–795. 10.1007/s00401-012-1038-9 - DOI - PMC - PubMed
    1. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, Sanchez-Valle R, Vilaseca I, Lomeña F, Vilas D, Lladó A, Gaig C, Santamaria J (2013) Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 12:443–453. 10.1016/S1474-4422(13)70056-5 - DOI - PubMed
    1. Kam K, Vetter K, Tejiram RA, Pettibone WD, Shim K, Audrain M, Yu L, Daehn IS, Ehrlich ME, Varga AW (2023) Effect of aging and a dual orexin receptor antagonist on sleep architecture and non-REM oscillations including an REM behavior disorder phenotype in the PS19 mouse model of tauopathy. J Neurosci 43:4738–4749. 10.1523/JNEUROSCI.1828-22.2023 - DOI - PMC - PubMed
    1. Lu J, Greco MA, Shiromani P, Saper CB (2000) Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 20:3830–3842. 10.1523/JNEUROSCI.20-10-03830.2000 - DOI - PMC - PubMed

Substances